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Abstract Imaging in rheumatology was in the past largely
confined to radiographs of the hands and sacroiliac joints
(SIJs) helping to establish the diagnosis and then monitoring
disease progression. Radiographs are not very sensitive for
early inflammation in inflammatory rheumatic disorders and
the demand on imaging services was therefore limited.
However, over the last 10–15 years new drugs and new
technologies have brought new challenges and opportunities
to rheumatology and radiology as specialties. New drug treat-
ments allow more effective treatment, preventing many com-
plications. Early diagnosis and disease monitoring has be-
come the challenge for the rheumatologist and radiologist
alike. The best possible patient outcome is only achieved if
the two specialties understand each other’s viewpoint. This
article reviews the role of imaging—in particular radiography,
magnet resonance imaging, computer tomography, ultrasound
and nuclear medicine—for the diagnosis and monitoring of
rheumatological disorders, concentrating on rheumatoid ar-
thritis, inflammatory spondylarthropathies and gout.
Teaching Points
• New drugs for the treatment of inflammatory disorders has
led to greatly improved outcomes.
• Imaging often allows for earlier diagnosis of inflammatory
disorders.
• Early diagnosis and treatment can often prevent the devel-
opment of crippling disease manifestations.
• Tailored imaging examinations are best achieved by consul-
tation of rheumatologist and radiologist.
Keywords Rheumatology . Radiology . Rheumatoid
arthritis . Inflammatory spondylarthropathy . Gout
Introduction
Imaging in rheumatology used to be largely about radiographs
of the hands and sacroiliac joints (SIJs) helping to establish the
diagnosis and then imaging of complications. Radiographs are
not very sensitive for recording change and often rheumatolo-
gists did not feel imaging had much to offer in inflammatory
rheumatic disorders and the demand on imaging services was
therefore limited. However, over the last 10–15 years new
drugs and new technologies have brought new challenges and
opportunities to rheumatology and radiology as specialties.
This article tries to explain the different perspectives of radiol-
ogists and rheumatologists.
Given the width and detail of investigations radiologists
can offer, it is surprising how little use some rheumatologists
make of the imaging options available and how little some
radiologists understand the crucial role imaging can play in
determining patient outcome.
This article aims to discuss the relevance of imaging for the
rheumatologist, concentrating on rheumatoid arthritis, inflam-
matory spondylarthropathies and gout.
Recent changes in the drug treatment of rheumatological
diseases
The treatment of rheumatological disorders has undergone a
dramatic change in the last 10 years or so. The days of pain-
killers plus steroid and sub-optimal use of conventional disease-
modifying anti-rheumatic drugs (DMARDs) for most inflam-
matory disorders are gone. When biological drugs became
available, treatment directed at key players involved in the
pathogenesis of the disease rather than just symptomatic treat-
ment became possible. Monoclonal antibodies or other biolog-
ical agents which inhibit tumour necrosis factor α (TNFα) and
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interleukin 6 (IL-6) or bind to the CD20 antigen on B cells
(rituximab) or interfere with activation of T cells (abatacept)
have been proven to significantly improve clinical outcomes.
Following demonstration of the efficacy of TNF inhibitors
in rheumatoid arthritis many rheumatologists were surprised
when they were also shown to be effective in ankylosing
spondylitis and psoriatic arthritis, given the different clinical
and radiological features of these disorders and the fact that
different immunological pathways appeared to be involved.
However, currently it is not possible to predict who will
respond favourably to any given drug. Differences are emerg-
ing between rheumatoid arthritis and the seronegative
spondyloarthropathies. Despite their efficacy in rheumatoid
arthritis, neither abatacept [1] nor tocilizumab [2] appears to
be effective in ankylosing spondylitis. Such observations un-
derline the importance of precise clinical diagnosis, in which
imaging has an important role to play.
What the rheumatologists need and what they don’t need
The earlier treatment is started the more favourable the long-
term prognosis. It has become possible to delay or even
prevent severe joint inflammation and subsequent destruction
[2, 3]. To enable early treatment early diagnosis becomes
paramount. However, inflammatory joint disorders often start
gradually and the clinical features can be non-specific. Not so
long ago, several years might have passed before a definite
diagnosis was made, by which time irreversible joint damage
or destruction had usually occurred.
To enable earlier diagnosis, various rheumatological soci-
eties have reviewed their diagnostic criteria and incorporated
modern imaging methods and modalities into their diagnostic
algorithms.
The role of imaging and radiologists is reviewed according
to disease entities (Table 1). When assessing different types of
inflammatory rheumatic disorders, the rheumatologist usually
requests imaging studies to answer one or more of the follow-
ing questions:
1. Is there evidence of an inflammatory process?
2. If so which anatomical sites are involved?
3. What is the specific diagnosis?
4. How is the disease responding to treatment?
Rheumatoid arthritis
Rheumatoid arthritis is still a disease of unclear aetiology. It is
an autoimmune disease with a genetic predisposition involv-
ing many genes and women are more commonly affected than
men. What exactly triggers its onset is subject to lively scien-
tific debate, but it seems likely that once the causative abnor-
mal immune process is established in the patient, it becomes
self-perpetuating.
Rheumatoid arthritis is largely a synovial based disease with
the potential for severe joint destruction, but it often has sys-
temic manifestations. Some authors have suggested that syno-
vitis might be secondary to a more basic disease process first
occurring within medullary bone as primary inflammatory
infiltrate [4–7], but this is subject to debate and not universally
accepted [8]. Intriguingly, Ostendorf and co-workers [6, 9]
found that bone scintigraphy has demonstrated increased bone
turnover in some patients with rheumatoid arthritis without
correlating magnet resonance imaging (MRI) findings, while
in most patients bone scintigraphic uptake correlated well with
MRI changes.
Older classifications of rheumatoid arthritis were insensi-
tive to early rheumatoid arthritis and years could pass between
onset of symptoms and definite diagnosis. However studies
have shown that the best outcomes are achieved by aggressive
treatment within 3–6months of onset of symptoms [4, 10, 11].
The availability of biologic disease modifying anti-rheumatic
drugs has moved the goalposts and enables disease control
and joint preservation unknown in the past but only if treat-
ment is started early enough.
Subsequently the diagnostic criteria for rheumatoid arthritis
were revised. The 2010 American College of Rheumatology/
European League against Rheumatism (EULAR) classifica-
tion assesses joint involvement, blood parameters and dura-
tion of symptoms. Unlike the previous criteria, imaging is not
part of this primary assessment, though radiographs of the
hands might be obtained at the time of diagnosis to establish
baseline findings [12], although, clearly, radiographs are in-
sensitive for the early diagnosis of inflammatory joint disease.
Radiographs can be used to monitor disease progression,
although they are insensitive for minor change.
Disease activity and response to treatment are usually
assessed by clinical criteria and blood tests. For straightfor-
ward cases of rheumatoid arthritis, the rheumatologist might
therefore not need much or any imaging input.
Imaging is, however, required for all cases that are not
straightforward. Patients presenting with fairly non-specific
Table 1 Usefulness of the various imaging modalities for the early
diagnosis of inflammatory joint disorders
X-ray US MRI Nuclear
medicine
CT
Rheumatoid arthritis – + + + –
Inflammatory
spondylarthropathy
– +− ++ + +−
Gout +− +− +− – +−
– means not usually useful, +−means may or may not be useful depend-
ing on clinical circumstances, + means usually useful, ++ means method
of choice
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aches, not fulfilling the diagnostic criteria for rheumatoid
arthritis or other inflammatory disease, might be early presen-
tations of these disorders, and imaging can help in the differ-
ential diagnosis of inflammatory rheumatic disorders. As early
diagnosis results in far better long-term outcomes, a wait and
see approach is no longer acceptable.
The questions asked of the radiologist in these cases are
typically some or all of these.
Is there inflammation? Which joint or organ is affected?
What is the anatomical pattern of involvement?
Radiographs
Radiographs are insensitive to most forms of soft tissue in-
flammation and usually play little role in these cases [3, 13].
Radiographs of the hands or other inflamed joints mostly
show normal bone structure and alignment in early disease
(Fig. 1) and are requested by some rheumatologists to estab-
lish a baseline. The earliest radiographic findings or rheuma-
toid arthritis are periarticular soft tissue swelling, followed by
osteopenia and bone erosions. In early disease the joint space
may appear widened due to joint effusion and synovitis. In
latter stages joint destruction, bone union and malalignment
may occur (Fig. 2). The early disease stages, soft tissue
swelling, osteopenia and even bone erosions are still revers-
ible. Obviously once cartilage destruction has occurred this is
irreversible and, even if the rheumatoid arthritis is halted,
secondary osteoarthritis will ensue [3, 4, 9, 13–15].
MRI
MRI is a very sensitive examination for inflammation be it in
soft tissue or bone. Clearly there has to be some understanding
of which areas are to be investigated. Whole-body MRI is not
well suited for the assessment of rheumatoid arthritis because
the small joints in particular are not well imaged. In early
disease the use of contrast medium enhancement can increase
the sensitivity for mild tenosynovitis, joint synovitis and bone
marrow signal change (Fig. 3) [3, 13, 15]. If contrast medium
administration is performed as a dynamic examination, the
contrast medium enhancement curve can be reviewed and
assessed for its enhancement pattern, further increasing the
sensitivity and specificity of the examination [16]. To perform
a dynamic contrast-enhanced examination the area of interest
is repeatedly imaged. Usually the image acquisition begins
before the contrast-medium injection or immediately after the
injection, before the contrast medium can circulate to the
examined area. This way it is possible to subtract the anatom-
ical image information and display the inflow of contrast
medium into the area of interest; this allows the speed and
intensity of contrast-medium enhancement to be observed,
which in turn allows conclusions to be drawn about the target
tissues. It might also permit assessment of disease activity.
However, in most cases the rheumatologist simply wants to
know whether inflammation is present—and, if so, where?—
and a dynamic examination is not necessary.
Dynamic contrast-medium-enhanced MRI is ideally done
by imaging the whole volume of interest, for example with a
three-dimensional (3D) sequence. Using a 3D sequence puts
higher demands on the scanner hardware but is otherwise no
different from using conventional 2D sequences.
Delayed post-contrast-enhancement MRI is not always
able to differentiate between synovium and joint fluid because
it might only take a few minutes for contrast medium to
diffuse into perisynovial fluid, particularly in cases of florid
inflammation [17].
MRI in rheumatology imaging can be reported using ref-
erence sets and scoring systems. The European league against
rheumatism (EULAR) has published reference atlases and
viewing instructions [18–20] which are available on the
EULAR website (www.eular.org). One of the main reasons
for this is that in many countries rheumatologists perform and
Fig. 1 A 45-year-old woman
with known rheumatoid arthritis,
complaining of recurrence of mild
symptoms after reduction of
methotrexate medication.
Radiographs of the hands were
normal (shown here X-ray left
hand, a). Ultrasound
demonstrates a bone erosion of
the second metacarpal head with
mild hypervascularity (b),
indicating active mild
inflammation. Ultrasound is far
more sensitive than radiography
for inflammatory joint change
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interpret imaging investigations like ultrasound and MRI
themselves. It has been shown that rheumatologists largely
concentrate on short tau inversion recovery (STIR) images
when interpreting MRI and also relying heavily on contrast-
medium-enhanced T1-weighted (T1w) images, while relative-
ly ignoring conventional T1w images [21–23]. This is
reflected in the published literature, particularly in the rheu-
matological literature and can lead to discrepancies in pub-
lished recommendations.
The outcome measures in rheumatoid arthritis clinical trials
(OMERACT) MRI study group recommends that MRI stud-
ies should include at least imaging in two planes, T1w imag-
ing before and after intravenous gadolinium based contrast
medium, and a fluid-sensitive sequence such as fat saturated
T2 (T2 fat sat) or a STIR sequence. If the examination is
performed to assess destructive bone changes such as ero-
sions, then i.v. contrast medium enhancement is not manda-
tory. The image slice thickness should be 3-4 mm with an
interslice gap of 10 % [24]. Any disease process leading to an
increased amount of fluid will show increased signal on the
fluid sensitive sequences (T2 fat sat and STIR) and decreased
signal in T1w images.
Last but not least, MRI might be requested when typical
complications of rheumatoid arthritis are suspected such as
erosion of the dens axis and transverse ligament of the atlas
leading to atlantoaxial instability. Plain films can be difficult to
assess in these circumstances and MRI not only demonstrates
the amount of erosion and inflammation but can also assess
possible neural compromise.
Ultrasound
Ultrasound is well able to assess superficial joints such as the
MCPJs of the hands for joint effusion, synovial proliferation
and synovitis as well as bone erosion (Fig. 1) [25]. It is
actually not very time-consuming once the small initial learn-
ing curve has been overcome. It can assess bursae and larger
joints and entheses. However, the more areas investigated the
more time-consuming it becomes. Naredo et al. [26] have
shown that for routine diagnostic and treatment response
purposes it suffices to assess the anterior and posterior recess
of the elbow, the dorsal carpal recess of the wrist, the second
and third MCPJ dorsally and palmar, the suprapatellar recess
Fig. 2 A 64-year-old woman with
severe long-standing rheumatoid
arthritis. A radiograph of the left
hand shows osteopenia, destruction
of the metacarpophalangeal joints
(MCPJs) and wrist joint, and fusion
of the carpal bones. Outcomes like
these should hopefully become
extinct with early diagnosis and
treatment
Fig. 3 A 53-year-old man with
bilateral inflammation of both
hands. Coronal T2 fat saturated
(fat sat) MRI (a) shows increased
fluid signal consistent with
synovitis and oedema in the wrist,
intercarpal and
metacarpophalangeal joints
(MCPJs) and also signal change
around the tendons suggesting
tenosynovitis. This was
confirmed with contrast-medium-
enhanced MRI of the hands. Here
shown are axial T1 fat sat images
at the level of the MCPJs (b) and
the wrist joints (c). Note the
erosions in the head of the right
second metacarpal (b , arrow)
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and the lateral parapatellar recess of the knee, the anterior
tibiotalar recess of the ankle and the medial and lateral tendon
sheaths in the ankle area. In a recent review Spencer et al. [25]
suggested more focused concentration on the wrist area and
the MCPJs for assessment.
Ultrasound can be combined with the use of contrast medi-
um, but this is not necessary as the most important question for
the rheumatologist is usually whether inflammation is present
or not, rather than trying to quantify disease activity. Even
disease response to treatment can be assessed with a semiquan-
titative score for synovitis and apart from scientific studies
contrast-enhanced ultrasound seems unnecessary [27, 28].
There are many competing assessment and scoring systems
and a near constant stream of publications in the rheumatology
literature assessing various aspects of this. This might be off-
putting for radiologists, but the relevance of these is limited
for most routine assessments. The rheumatologist knows best
which area he or she is interested in and, if indicated, which
scoring system is preferred.
When considering whether to use ultrasound or MRI it is
worth remembering that ultrasound cannot of course image
bone marrow. If this is important then MRI is clearly the
modality of choice. Ultrasound is well suited to assess a large
number of different joints for inflammation relatively quickly.
Whether ultrasound or MRI is more sensitive or specific for
synovitis and erosions in a given superficial joint is not yet
clear. The comparison is problematic because of the lack of a
“gold standard”: both modalities have been shown to miss
inflammatory soft tissue changes and erosive bone lesions [29,
30]. In larger, deeper joints such as the shoulder, MRI seems
more reliable [13].
Nuclear medicine
Nuclear medicine can and is still being used to assess inflam-
matory arthropathies. As with all imaging modalities, local
preference can vary significantly: availability, expertise, cost
and general familiarity all play a role.
In particular, the vascular and diffusion phase can provide
information about the presence and degree of inflammation.
The bone phase is much less specific and needs correlation
with radiographs for interpretation [9, 14]. High-resolution
single photon emission computed tomography (SPECT) in-
creases the spatial resolution and allows for better recognition
of bone erosions and lesions. Ostendorf et al. [9] even found
increased activity in a few patients with normal MRI. It was
unclear, though, whether these were patients who would go on
to develop rheumatoid arthritis. A study by Ozgul et al. [31]
found bone scintigraphy of limited value in predicting or
identifying rheumatoid arthritis in patients with early undif-
ferentiated arthritis. Duer et al. [32], however, found the
opposite: the three-phase bone scan performed in patients with
undifferentiated arthritis was able to predict the presence or
absence of rheumatoid arthritis 2 years later quite reliably. It is
also able to predict disease progression on later imaging and
was found to perform well compared with MRI [33]. More
recently a pilot study by Roimicher et al. [34] using Tc99-
labelled anti-TNFα antibodies showed promising sensitivity
(98.8 %) and specificity (97.3.%) when compared to MRI in
eight patients with rheumatoid arthritis, looking at 198 joints,
49 of which showed inflammation. By contrast clinical as-
sessment only reached a sensitivity of 59 % and specificity of
65 % when compared with MRI.
Overall these studies add to the uncertainty as to whether
there is truly an imaging gold standard in inflammatory arthri-
tis. More advanced nuclear medicine techniques do not play a
routine role in rheumatology imaging.
In summary, the rheumatologist might not need much
radiology in the diagnosis and management of rheumatoid
arthritis. If the diagnosis is clear, based on clinical and labo-
ratory parameters, no diagnostic imaging may be required.
Baseline radiographs of the hands are usually the only imag-
ing investigation.
If the diagnosis is not clear, imaging might be used to
establish the location or nature of inflammation. Which mo-
dality is preferred will depend partly on local availability and
expertise. For most questions, straightforwardMRI—possibly
with contrast-medium enhancement—and straightforward ul-
trasound will suffice. While additional information can be
gleaned by quantitative techniques, this is not necessary in
routine practice. If a particular scoring system is to be used,
this should be indicated by the rheumatologist.
Inflammatory spondyloarthropathies
Inflammatory spondyloarthropathies consist of a wide range
of diseases. The archetypical representative is ankylosing
spondylitis, but reactive arthritis (Reiter’s syndrome),
spondyloarthropathy associated with inflammatory bowel dis-
ease, psoriatic arthritis, undifferentiated spondyloarthropathy
and, arguably, Whipple’s disease and Behcet’s syndrome can
all be classed as inflammatory spondyloarthropathy. They are
linked to the HLA B27 antigen to variable degrees and
enthesitis is a key feature [35].
The patient might present with clinical features suggestive
of an inflammatory spondyloarthropathy, such as inflamma-
tory back pain, heel pain, peripheral arthritis, dactylitis or
similar, and imaging is requested to establish the diagnosis.
Differentiation from rheumatoid arthritis in the early stages of
the disease when there are limited clinical, laboratory and
imaging features can be difficult but establishing the correct
diagnosis is important [36].
In other cases the patient might be known to have an
inflammatory spondyloarthropathy and imaging is requested
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to narrow the differential diagnosis, e.g. psoriatic spondy-
loarthropathy versus classical ankylosing spondylitis.
MRI
The most frequent imaging request in this context is MRI of
the SIJs to look for sacroiliitis (Fig. 4). Radiographs can take
many years to show evidence of sacroiliitis and the bone scan
is unreliable (Fig. 5). Computer tomography (CT) is more
sensitive than radiography but cannot reliably show bone
marrow change [36, 37].
When requesting anMRI of the SIJs, rheumatologists often
request a contrast-medium-enhanced examination. The reason
for this is not clear to many radiologists and requests are
subsequently either ignored or performed grudgingly. The
reason many rheumatologists request a contrast-medium en-
hanced examination is that this is what is done in many of the
studies published in their literature. As discussed in the section
on rheumatoid arthritis, many imaging investigations includ-
ing MRI in countries outside the United Kingdom (UK) are
supervised and interpreted by non-radiologists, and they often
rely heavily on STIR and contrast-medium-enhanced T1w
(often T1 fat saturation) sequences and do not appreciate the
role of conventional T1w sequences. Radiologists, on the
other hand, use both sequences to assess the examined area
and usually do not require further sequences.
Most pathological disease processes are associated with an
increased amount of free fluid and this is seen as signal increase
on fluid-sensitive sequences such as T2 fat sat and STIR and
also as signal decrease on conventional T1w sequences. The
anatomical resolution of standard T1w sequences is usually
very high and allows for good anatomical correlation of the
findings. The combination of a fat-suppressed fluid-sensitive
sequence and a T1w sequence also allows to identify fatty (low
signal in fat sat, high in T1w) and sclerotic (low signal in all
sequences) bone marrow change.
Compared with STIR sequences, contrast-medium-
enhanced T1w sequences have not been proved to be superior
in assessment of spinal inflammation in studies by Baraklios
et al. [22] and Madsen et al. [38]. On the other hand, contrast-
enhanced T1w studies were found to be slightly superior to
STIR imaging in two other studies [39, 40].
The importance of training for the reliable diagnosis of
inflammatory spondyloarthropathy based on MRI has been
stressed [21], and reference instruction manuals and atlases for
this purpose have been published [41].
Contrast-medium enhancement and diffusion-weighted
imaging with MRI have been found to be more accurate for
quantification of treatment response in ankylosing spondylitis
[42]. Whether this proves useful in routine clinical imaging
remains to be seen.
The use of more exotic contrast medium such as (ultrasmall)
superparamagnetic iron oxide particles ([U]SPIO) has also been
investigated for the imaging of inflammatory bone marrow
lesions. The aim is to define the reason for bone marrow
oedema-like change more accurately. As SPIOs are taken up
by macrophages, signal change after SPIO administration
would indicate the presence of macrophages. This is usually
suggestive of infection or severe inflammatory spondyloar-
thropathy [43]. However this is a research application and
unlikely to come into routine practice soon or indeed ever
[44–46].
Whether an axial sequence is necessary or whether the
paracoronal plane alone is sufficient for imaging of the SIJs
is also subject to debate in the relevant literature [47]. Most
publications favour the use of the paracoronal plane only and
many radiologists are content with this. However, in almost all
imaging examinations it is regarded good practice to image in
two planes and this reduces uncertainty regarding partial
volume effects. The use of 3D sequences in the spine has
been found to be useful in this regard [48].
Usually the SIJs are imaged with a dedicated examination
focusing on the sacrum and SIJs. However, in clinical practice
Fig. 4 Coronal images of the
SIJs demonstrating typical
findings of acute or chronic
sacroiliitis with sclerosis, fatty
and oedema-like change as shown
on STIR (a) and T1w (b) images.
The diagnosis is not in question
804 Insights Imaging (2013) 4:799–810
the SIJs might be imaged as part of an MRI of the pelvis or a
whole-body MRI. It has been shown that even imaging with
straight coronal sequences with possibly slightly thicker slices
allows for reliable diagnosis of sacroiliitis [49].
The diagnostic criteria constituting sacroiliitis have been laid
out by theAssessment of Spondyloarthritis International Society
(ASAS). They are available online (http://www.asas-group.org)
or in print version [41] and are as follows:
Active inflammatory lesions of the SIJs, i.e. bone marrow
oedema (as seen on STIR) or osteitis (seen on T1w post
contrast-enhanced images), must be clearly present in typical
anatomical areas (subchondral or periarticular bone marrow
oedema). A single lesion on a single slice is not sufficient for
the diagnosis for sacroiliitis. The minimum criteria are two
lesions seen on at least one slice each or one lesion seen on
two adjacent slices. The presence of synovitis, enthesitis or
capsulitis on their own are not sufficient to diagnose sacroiliitis
on MRI. Structural changes such as fat deposition, sclerosis,
erosions or ankylosis are likely to be sequelae of previous
inflammation; however, in the absence of acute changes they
are not diagnostic of sacroiliitis [41, 50].
Interestingly there is no inclusion of imaging parameters
such as slice thickness or interslice distance and lesion size is
also not part of the assessment. This does in the authors’
opinion introduce an element of chance into the assessment.
A single lesion of the same size might be visualised on one or
two slices depending on its position relative to the centre of
the slice, i.e. if it is central it might be seen on one slice only, if
it falls onto the border of two slices it might be seen on two
slices and therefore fulfil the diagnostic criteria for sacroiliitis.
Or putting it another way, the thinner the slices the higher the
chance of diagnosing sacroiliitis.
Fig. 5 A 35-year-old man with psoriasis and psoriatic spondylarthropathy.
MRI of the pelvis demonstrates a single inflammatory lesion in the left SIJ
seen on two adjacent slices, this was best appreciated on the coronal STIR
sequence (a, b, arrows). This patient therefore has sacroiliitis. Had the
lesion been seen on only one slice, sacroiliitis could not be diagnosed using
the ASAS criteria. Sacroiliitis is not visible on the normal-appearing
radiograph of the SIJs (c). There is mild involvement of the spine. The
sagittal STIR sequence demonstrates mild bone marrow oedema-like
change on the anterior aspect of C2 (d, arrow) consistent with enthesitis.
The arthropathy is better seen in some costovertebral joints (e , arrow), axial
reformat of a sagittally acquired 3D sequence. Volume 3D sequences of the
spine enable assessment of all costovertebral and costotransverse joints and
can help make the diagnosis. The patient also complained of left foot pain,
sagittal T2 fat sat MRI showed enthesitis at the origin of the abductor digiti
minimi (f). Bone marrow lesions are not usually visible with ultrasound,
CT or radiographs. Whole body bone scintigraphy demonstrated several
areas of abnormal activity but the sacroiliitis and the spine involvement are
not appreciable (g)
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It is, however, necessary to sound a word of caution regard-
ing the use of MRI to diagnose axial spondyloarthritis
according to the ASAS criteria. More patients will meet these
criteria than the modified New York criteria, of whom a sub-
stantial proportion fail to meet the modified New York criteria
at follow-up [51]. The modified New York criteria look for
clinical signs of low-back pain improved by exercise but not
rest, limitation of lumbar movement and limitation of chest
expansion. Further, they assess for radiographic evidence of
sacroiliitis of either at least minimal sacroiliitis bilaterally or at
least moderate sacroiliitis unilaterally. If either radiographic
condition is fulfilled and there is at least one clinical sign, then
ankylosing spondylitis is diagnosed.
People with axial spondyloarthropathy are a more hetero-
geneous group and have a higher proportion of women and
more marked genetic differences compared with people with
classical ankylosing spondylitis.
There are a number of scoring systems for the assessment
of ankylosing spondylitis [52]. As discussed in the section on
imaging of rheumatoid arthritis, if this is desired the rheuma-
tologist should indicate which system is preferred.
Similarly there are scoring systems for other inflammatory
spondylarthropathies such as psoriasis, for example the
OMERACT Psoriatic Arthritis Magnetic Resonance Imaging
Score (PsAMRIS) [53]. Should the use of a particular scoring
system be of interest, the rheumatologist should indicate this.
Radiographs and CT
Radiographs might show evidence of bone erosion and/or
other reactive bone change with ankylosis of the spine the
most extreme form of reactive bone change. While it is, of
course, important to note these findings and suggest the diag-
nosis if unsuspected, radiographs are of limited value in the
diagnosis of early inflammatory spondyloarthropathy because
of the high false-negative rate (Fig. 5). To an even greater
extent than in rheumatoid arthritis, the radiographic changes
often lag behind the clinical presentation by years [4, 21, 37].
Nevertheless, rheumatologists in the UK often request plain
X-rays because the current UK NICE (National Institute for
Health and Care excellence) criteria for the use of TNF-
inhibitors in ankylosing spondylitis require that the patient
fulfils the modified New York radiographic criteria [54].
While CT is more sensitive for reactive bone change it is
insensitive for oedema-like change of bone marrow or soft
tissues and MRI is preferred for this [36, 37].
Nuclear medicine
Bone scintigraphy in particular has been used in the past to seek
sacroiliitis. Activity ratios of the SIJs versus normal-appearing
bone areas can be calculated, but a literature review by Song
et al. [55] found the sensitivity with this method to be just over
50 % and therefore quite poor (Fig. 5). It has been suggested
that bone scintigraphy be combined with bone marrow scintig-
raphy but doubts regarding the usefulness of this technique
remain [56].
One advantage of bone scintigraphy is that it is by its nature
a whole-body imaging technique and hence useful for identifi-
cation of inflammatory lesions in joints and entheses which are
not necessarily apparent clinically. The pattern of involvement
can give important diagnostic clues or might detect hitherto
unrecognised areas of disease involvement. The combination
with single photon emission computer tomography (SPECT)
increases anatomical resolution.Whole-body bone scintigraphy
might also help differentiate inflammatory spondyloarthro-
pathies from other inflammatory disorders such as SAPHO
(synovitis, acne, pustulosis, hyperostosis, osteitis), e.g. by dem-
onstrating the pathognomonic “bull’s head” appearance of
SAPHO (Fig. 6) [57, 58].
Positron emission tomography (PET)-CT can be used for
the diagnosis of inflammatory lesions such as sacroiliitis [59]
but the limited availability, cost and radiation dose restrict this
technique to scientific interest only for the time being.
Ultrasound
While ultrasound is, of course, not suited to assess bone mar-
row disease or spinal arthropathy, it is well suited to look for
peripheral enthesitis and can be surprisingly useful in inflam-
matory spondyloarthropathies [60]. It has even been applied to
the diagnosis of sacroiliitis as a low tech alternative to MRI
[61]. Orientating ultrasound assessment of major entheses has
been suggested in suspected or established cases of inflamma-
tory spondylarthropathies, either to support or refute the diag-
nosis or to help establish the disease burden [62–64].
D’Agostino et al. [64] assessed about 200 patients with an
inflammatory spondyloarthropathy or rheumatoid arthritis and
more than 60 controls. They sonographically examined the
major entheses of the limbs, the greater trochanters, pubis,
patellae, Achilles tendon insertion, planta fascia origin, tibialis
anterior insertions, medial and lateral epicondyles. This took
about 20 min and identified more than double the number of
areas of enthesopathy as were apparent clinically in the inflam-
matory spondyloarthropathy group. The pattern of inflamma-
tion of entheses or joints can sometimes help to distinguish
rheumatoid arthritis from inflammatory spondyloarthropathies
and might be requested for this reason. The sonographic find-
ings as such cannot differentiate the various inflammatory
spondylarthropathies.
Tinazzi et al. [65] suggested that ultrasound can help to
predict the likelihood of developing psoriatic arthropathy in
patients with psoriasis based on sonographically visible but
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clinically asymptomatic tendon changes. Ultrasound can also
be used to assess treatment response and shows decreased
inflammation, decrease tendon and enthesis thickness and
increase in echogenicity under successful therapy [66].
In conclusion, imaging in inflammatory spondyloarthro-
pathies extends beyond assessment of sacroiliitis, although this
examination is probably most frequently requested, and early
diagnosis and treatment with TNF-inhibitors can result in a
profound improvement in long-term morbidity. There are still
requests for radiographs of the SIJs for suspected sacroiliitis and
there is an onus on radiologists to publicise the advantages of
MRI for early diagnosis. In addition to sacroiliac imaging focal
joint or spine imaging can help to assess disease burden and
differential diagnosis and can be used to guide steroid injections.
Fig. 6 A 57-year-old woman
with sternoclavicular joint pain.
MRI showed bone marrow
oedema-like change and synovitis
in relation to the sternoclavicular
joints and less marked in relation
to the corpomanubrial joint of the
sternum (a , coronal STIR). Bone
scintigraphy demonstrated
increased activity in this area, the
so-called Bull’s head sign (b).
The patient was diagnosed with
SAPHO
Fig. 7 A 73-year-old man with
anterior knee pain and soft tissue
swelling suspicious for bursitis.
Ultrasound demonstrated a highly
echogenic prepatellar mass, not
typical for bursitis (a , sagittal
extended field of view image).
MRI in T1w (b , sagittal) and
T2w (c , axial) showed a lowish
signal T1 and mixed signal T2
lesion. The appearances are
unspecific. Biopsy confirmed a
gout tophus. Gout tophi can have
varied appearances on MRI, the
diagnosis in atypical locations in
difficult based on imaging alone
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Gout
Imaging had a limited role to play in gout until recently
because soft tissue opacification and bone lesions do not
appear until the later stages of the disease, by which time the
diagnosis is usually obvious clinically.
However, the clinical presentation and history of gout are
not always typical; the serum urate can drop within the normal
range during an acute attack and the “gold standard” for
diagnosis, i.e. identification of urate crystals in joint fluid, is
frequently not practicable.
Gouty lesions can, however, be identified readily by ultra-
sound and MRI, which offer scope for improvement in the
management of the condition.
Ultrasound can be used to demonstrate tophi and synovial
changes, and demonstrates most of the lesions seen on MRI. A
double-contour sign (a hyperechoic irregular band over the artic-
ular cartilage best seen on the dorsal side of metatarsophalangeal
joints) is considered to be pathognomonic. It is thought to
represent a layer of urate crystals over the cartilage [67].
However, tophi are sonographically unspecific in appearance
(Fig. 7). Compared with MRI, ultrasound is less sensitive as
regards to cortical erosions, but better than radiographs.
Although changes can be detected over time, it remains unclear
whether serial assessment of tophi, synovial change or erosions
will prove most useful in the management of gout.
MRI can also be used to demonstrate tophi, synovial
changes and erosions. Although less operator-dependent than
ultrasound, the lower cost and greater accessibility of the latter
are likely to make it the more popular modality for the imag-
ing of gout [68].
The MRI findings of gout obviously depend on the clinical
presentation/stage of the disease. Once a tophus has devel-
oped, this is visible on MRI imaging, but unfortunately the
findings are not pathognomonic. In T1w a tophus is typically
isointense to muscle and in T2w the signal intensity can vary
between hypointense and hyperintense, with an intermediate
signal intensity most common. This can cause diagnostic
difficulties and if a tophus is seen in an atypical location even
a malignant soft tissue mass may be considered. Other crystal
arthropathies, such as calcium pyrophosphate deposition disease,
and disorders, such as rheumatoid arthritis, may also have similar
imaging findings. Contrast-medium-enhancement is often seen
[69]. The best discriminators are typical location and clinical
presentation, the presence of typical bone erosions is also helpful
for the diagnosis. There is no special imaging protocol showing
pathognomonic findings.
CT imaging can be helpful, gout tophi typically demon-
strate attenuation values of 150–200 Hounsfield units (HU)
and this can be diagnostically helpful (Fig. 8). More recently,
dual-energy CT has been found to be more specific in identi-
fying gouty deposits [70, 71].
Earlier diagnosis by either of these methods should accel-
erate definitive treatment with urate-lowering treatment such
as allopurinol or febuxostat, not least because the demonstra-
tion of an established burden of crystalline deposits will help
to persuade patients to start such treatment. Modern treatment
of gout aims to lower the serum urate well below its solubility
limit in tissue fluid [72, 73]. This leads to resorption of
tophaceous material which will reduce and eventually prevent
further attacks of gout. Ultrasound or MRI can now be used to
monitor that such resorption is taking place.
Conclusion
In the authors’ institution, the clinical practice of rheumatol-
ogists and radiologists varies amongst individuals. This is in
the authors’ view normal and reflects different training, expe-
rience and personal preference.
Between the specialties there are areas of mutual misunder-
standing which are best resolved by a closer working relation-
ship. Imaging can make a huge difference for long-term patient
outcome. The pros and cons of using different imaging tech-
niques are within the remit of radiologists (otherwise what is our
point?). Both specialties have a duty to use imaging in a cost-
Fig. 8 An 82-year-old man with pain and inflammation in the forefoot.
CT demonstrates soft tissue (a coronal reformat of the forefoot, sagittal
reformat of the big toe) and destructive bone and articular (b , arrows)
deposits, hyperattenuating compared with muscle and hypoattenuating
compared with bone. The attenuation values were around 200 HU
confirming the clinical diagnosis of gout. Masses with attenuation of
150–200 HU are usually due to gout tophi
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effective manner to provide the requisite clinical information on
diagnosis, prognosis and serial assessment with the least risk and
inconvenience to the patient. This can be best achieved by close
working relationships between the specialties.
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